slides · global inventory
Problem Agitate Solution
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 26,550
Current window 21,541-21,570
Pages 885
Rows per page 30
Arc
21,541-21,570 of 26,550
01
Diageo | Investor Event Presentation Deck | 63 slidesDiageo | Investor Event Presentation Deck | 63 slides · Diageo
Conference presentation Investor relations Beat · Attention1 hit
02
Diageo | Investor Event Presentation Deck | 63 slidesDiageo | Investor Event Presentation Deck | 63 slides · Diageo
Conference presentation Investor relations Beat · Attention1 hit
03
Diageo | Investor Event Presentation Deck | 63 slidesDiageo | Investor Event Presentation Deck | 63 slides · Diageo
Conference presentation Investor relations Beat · Attention1 hit
04
Diageo | Investor Event Presentation Deck | 63 slidesDiageo | Investor Event Presentation Deck | 63 slides · Diageo
Conference presentation Investor relations Beat · Attention1 hit
05
The slide uses a checkmark list to emphasize strategic pillars.Diageo | Investor Event Presentation Deck | 63 slides · Diageo
Conference presentation Investor relations Beat · Attention1 hit
06
TBA likely stands for Total Beverage Alcohol.Diageo | Investor Event Presentation Deck | 63 slides · Diageo
Conference presentation Investor relations Beat · Interest1 hit
17
The slide uses a before-after framework to illustrate the physiological impact of the drug.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
18
Uses a before-after framing to explain the mechanism of action for Ampreloxetine.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
19
The slide uses a process-flow layout to connect mechanism to clinical outcomes.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
20
The chart is a forest plot showing LS Mean differences with 95% confidence intervals for various OHQ questionnaire scores.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
21
The slide outlines a clinical trial methodology using a randomized withdrawal design.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
22
The slide uses a combination of market sizing metrics and a competitive product comparison table.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
23
Theravance Biopharma | Results Presentation Deck | 41 slidesTheravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
24
Includes GAAP and non-GAAP financial data.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
25
Includes per share data and share counts for basic and diluted calculations.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
26
The slide emphasizes the company's improved financial position, specifically the reduction in debt and share buybacks.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
27
Theravance Biopharma | Results Presentation Deck | 41 slidesTheravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
28
The chart shows a significant reduction in operating expenses from 2020 to 2023 guidance.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
29
Uses a timeline-like arrow structure to represent progression of value drivers.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
30
Theravance Biopharma | Results Presentation Deck | 41 slidesTheravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
31
Standard pharmaceutical product disclosure slide.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
32
Theravance Biopharma | Results Presentation Deck | 41 slidesTheravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
33
Theravance Biopharma | Results Presentation Deck | 41 slidesTheravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
34
Includes definitions for COPD, nOH, and PTE in the footer.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
35
The slide uses a mathematical formula structure to explain revenue recognition.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
36
The table displays projected royalties and milestones for 2023-2026, while the right side details royalty return dates for 2029 and 2031.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
37
The slide uses two distinct colored containers to contrast the two different drug deal structures.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
38
Uses a funnel diagram to illustrate market penetration.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
39
Slide 39 of a presentation deck.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
40
The slide contrasts a narrow 'dizziness' focus with a broader 'constellation of symptoms' approach for MSA patients.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit